Gordon, K. B., Langley, R. G., Warren, R. B., Okubo, Y., Rosmarin, D., Lebwohl, M., Peterson, L., Madden, C., de Cuyper, D., Gomez, N. N., & Thaçi, D. (2022). Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials. SKIN The Journal of Cutaneous Medicine, 6(6), s66. https://doi.org/10.25251/skin.6.supp.66